Back

Heterogenous treatment effects: secrets for a reliable treat-to-target trial?

Cardiovascular Research

17 May 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Tomasz J Guzik
Tomasz J Guzik

Author

University of Edinburgh Edinburgh , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Session
HFA clinical trial course in a nutshell
17 May 2025
thumbnail
Congress Presentation
Predicting individualized treatment effects of prasugrel vs ticagrelor for acute coronary syndrome: a post hoc analysis of a randomized clinical trial
31 August 2025
thumbnail
Congress Presentation
Cardio-rheumatology: what can we learn from rheumatoid arthritis treatment?
4 April 2025
thumbnail
Congress Presentation
Outcomes associated with modern treatment paradigms in connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH): a meta-analysis of randomized controlled trials (RCTs)
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources